How many institutions held KLRA - Kailera Therapeutics, Inc. - Common Stock, $0.00001 par value in Q2 2026?

100 institutional investors reported KLRA - Kailera Therapeutics, Inc. - Common Stock, $0.00001 par value for Q2 2026. Use the holders table for investor-level position and value details.

Kailera Therapeutics, Inc. - Common Stock, $0.00001 par value (KLRA)

Q: What does CUSIP 482931102 represent in this 13F holders report?

CUSIP 482931102 is the security identifier for KLRA - Kailera Therapeutics, Inc. - Common Stock, $0.00001 par value used to aggregate holder disclosures.

CUSIP: 482931102

Q2 2026 13F Holders as of 30 Jun 2026

Security type / class: Equity / Common Stock, $0.00001 par value
Total 13F shares: 116,882,480
Total 13F value: $2,574,896,350
Share change: +115,904,623
SEC-reported price per share: $22.03
Number of holders: 100
Value change: +$2,553,397,849
Number of buys: 98
Shares outstanding: 129,841,205

Security key

482931102

Report period

Q2 2026

Institutions

100

Top holders

KLRA full security history Ownership snapshot Full 13F holder table Newer quarter: Q3 2026 Kailera Therapeutics, Inc. SEC filings Kailera Therapeutics, Inc. company facts

Broader feeds

Latest 13F filings Latest 13D/G filings Investors directory

Reporting periods

Holder history for CUSIP 482931102

Newer quarter: Q3 2026

Recent filing periods:

Q3 2026 Q2 2026

Ownership snapshot

Top reported holders of KLRA - Kailera Therapeutics, Inc. - Common Stock, $0.00001 par value (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.

Comparable stake leader

Jiangsu Hengrui Pharmaceu...

Disclosed value leader

Jiangsu Hengrui Pharmaceu...

Comparable rows

3/15

Latest evidence

30 Jun 2026

13D/G 3/4/5 Lead comparable stake: 8.9% 12 rows are not safely comparable across share classes. 13D/G row: Jiangsu Hengrui Pharmaceuticals Co., Ltd. Showing 1-6 of 15 holder rows.

Quick read

Jiangsu Hengrui Pharmaceuticals Co., Ltd. leads the comparable SEC ownership view at 8.9%.

3 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.

Open SEC evidence Opens Jiangsu Hengrui Pharmaceuticals Co., Ltd.'s linked filing trail.

Comparable ownership Top 3

Jiangsu Hengrui Pharmaceuticals C... 8.9%

RTW INVESTMENTS, LP 8.3%

CANADA PENSION PLAN INVESTMENT BOARD 5.6%

Ownership % is shown only when SEC disclosures are safely comparable across share classes.

Detailed SEC evidence table Showing 1-6 of 15 holder rows

Holder	Evidence	Ownership %	Position	12M Net Δ	As of
Jiangsu Hengrui Pharmaceuticals Co., Ltd.	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	8.9%	$238,065,120 11,511,853 shares	$0	30 Jun 2026
RTW INVESTMENTS, LP	13D/G 3/4/5 10%+ Owner 13D/G 3/4/5	8.3%	$222,864,638 10,776,820 shares	$0	30 Jun 2026
CANADA PENSION PLAN INVESTMENT BOARD	13D/G CPP Investment Board Private Holdings (4) Inc. 13D/G	5.6%	$151,060,948 7,304,688 shares	$0	30 Jun 2026
Kaplan Andrew T.	3/4/5 Director, 10%+ Owner 3/4/5	— mixed-class rows	— 26,293,881 shares mixed-class rows	—	16 Apr 2026
Bain Capital Fund XIV, L.P.	3/4/5 10%+ Owner 3/4/5	— class O/S missing	— 26,255,581 shares	—	20 Apr 2026
BAIN CAPITAL INVESTORS LLC	3/4/5 10%+ Owner 3/4/5	— class O/S missing	— 26,255,581 shares	—	20 Apr 2026

How to read this table

Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

13F holder rows

Institutional holders as of Q2 2026

Investor-level positions for this CUSIP, loaded as an interactive table.

Institutions

100

116,882,480

Rows available

100

Investor	Option	Weight %	Change %	SEC-reported value	* Price	Shares	Share Change	Activity	Report Period

^* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.

Compare Q2 2026 vs Q2 2026 Across Filers

Q2 2026 holders

100

Q2 2026 holders

100

Holder diff

Investor	Q2 2026 Shares	Q2 2026 Shares	Share Diff	Share Chg %	Q2 2026 value	Q2 2026 value	Value change	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend